447 related articles for article (PubMed ID: 24397896)
1. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
[TBL] [Abstract][Full Text] [Related]
2. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
[TBL] [Abstract][Full Text] [Related]
5. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
[TBL] [Abstract][Full Text] [Related]
6. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
7. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
8. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Sricharoenchai S; Sirivichayakul C; Chokephaibulkit K; Pitisuttithum P; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chinwangso P; Poredi IK; Petre J; Thai PH; Viviani S
Lancet Infect Dis; 2018 Jan; 18(1):58-67. PubMed ID: 29066131
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the immune response induced by pertussis OMVs-based vaccine.
Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model.
Kang KR; Huh DH; Kim JA; Kang JH
BMC Immunol; 2021 Oct; 22(1):68. PubMed ID: 34641798
[TBL] [Abstract][Full Text] [Related]
11. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
Lavigne MV; Castro M; Andino J; Manghi M
Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
Med Dosw Mikrobiol; 2007; 59(2):137-47. PubMed ID: 17929411
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles.
Ormazábal M; Bartel E; Gaillard ME; Bottero D; Errea A; Zurita ME; Moreno G; Rumbo M; Castuma C; Flores D; Martín MJ; Hozbor D
Vaccine; 2014 Oct; 32(46):6084-90. PubMed ID: 25240753
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
[TBL] [Abstract][Full Text] [Related]
16. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.
Stenger RM; Smits M; Kuipers B; van Gaans-van den Brink J; Poelen M; Boog CJ; van Els CA
Vaccine; 2010 Sep; 28(40):6637-46. PubMed ID: 20637762
[TBL] [Abstract][Full Text] [Related]
17. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
[TBL] [Abstract][Full Text] [Related]
18. Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen.
Lavigne MV; Castro M; Mateo N; Deluchi S; Atzori C; Piudo L; Calcagno M; Brero ML; Manghi M
Microbes Infect; 2002 Jul; 4(8):815-20. PubMed ID: 12270728
[TBL] [Abstract][Full Text] [Related]
19. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
[TBL] [Abstract][Full Text] [Related]
20. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
